JAK1 and endometrial cancer: JAK1 mutations were associated with impaired upregulation of antigen presenting machinery proteins LMP7 and HLA class I. The association of JAK1 mutations with limited expression of the antigen presentation pathway was validated using RNAseq data of the TCGA MSI endometrial cancers.